Creo Medical Share Discussion Threads

[bloomberg2] 31/12/2024 11:30

Nice liccle santer rally today

[peterrr3] 30/12/2024 12:03

Anyone??? Not even the company could be bothered upticking this media campaign. I hope the external comms team are being paid by the number of Likes, in which case it should cost no more than a tenner.

[peterrr3] 30/12/2024 11:59

12 days of Creo anyone?

[imjustdandy] 20/12/2024 13:55

Looking fantastic at long last

[bloomberg2] 20/12/2024 13:15

https://youtube.com/shorts/jQs47KuO6eg?si=JZJNf4DXo2TjRGY9

[imjustdandy] 19/12/2024 14:56

This is one for 2025. An easy double from here at 17

[imjustdandy] 17/12/2024 01:22

That's 850,000 pounds

[imjustdandy] 17/12/2024 01:22

Directors have now purchased over £850k of shares since October. The majority at 24p

[imjustdandy] 16/12/2024 21:40

Tidy Director buy today. 200 grand - lovely

[peterrr3] 16/12/2024 13:58

I should add I think your chart work looks on the money, although I am more of a fundamentalist.

[peterrr3] 16/12/2024 12:49

The clinical trials database is the main thing that matters Protrader, but here is are a couple more fact based sites I have posted below:WIPO pretty much all good herehttps://patentscope.wipo.int/search/en/result.jsf?_vid=P10-M4R143-39929NICE. not selected for review yethttps://www.nice.org.uk/guidance/awaiting-development/gid-mt602I'm afraid I don't trust non independent analysts or company produced revenue predictions for most AIM stocks. But please share your in depth research, Kings prize for innovation is some of the irrelevant rubbish that comes to mind.

[dr biotech] 16/12/2024 10:05

It is actually from Peters link. At the top of the page you can see all 8 trials that Creo are involved in and their current status (fwiw the page lists 9 studies, but the last one seems to be irrelevant). Some of these could report towards the end of feb next year or sooner, though I would normally expect some slippage as completion dates are often optimistic.

The 6/8th trials seems to have stopped, though the East Kent trust has published some favourable data from the first.

My understanding is that the trials will be recruiting up until the near end of the completion date. Its a bit different to a dosage trial as you don't have a placebo group. A few of the trials seem new, which ties in with the statement given with the results.

---

Decent sized purchase from the chair. He has put his wallet on the line which is a decent vote of confidence.

[protrader3] 16/12/2024 08:52

Peterrr3 why don't you do some research yourself and stop asking other people? For someone who is supposedly invested you are very negative. Getting a little boring now.

[peterrr3] 16/12/2024 08:43

Where is your evidence for the progression of the trials Dr B. The US clinical trials database is used and updated not so long ago for most trials but apart from a change in some of the outcomes they are measuring and dates moving right for some I don't see any progress.

[imjustdandy] 16/12/2024 08:25

200,000 quid is a proper Director buy. I would expect the other Directors will follow now too. 24p the last placing price which they Directors also participated.

[protrader3] 16/12/2024 08:22

That's a big vote of confidence.

[imjustdandy] 16/12/2024 08:09

Excellent Director buy

[bloomberg2] 16/12/2024 07:52

Creo Medical Group - Director/PDMR Shareholding #CREO @CreoMedical https://www.voxmarkets.co.uk/rns/announcement/b7145a4a-507a-4212-9f60-6de198ef2813 #voxmarkets undefined

[bloomberg2] 16/12/2024 07:18

Nice director purchase

[dr biotech] 13/12/2024 10:14

Looks like quite a few of those trials have progressed. Hope some will report within the next few months.

I don’t see any particular reason for the small recovery, just oversold. Would be happy to be proved wrong.

[peterrr3] 13/12/2024 10:03

Given the directors didn't buy yesterday maybe you are right there Foetus. I'm definitely not complaining about the newfound popularity.

[foetus in your brain] 13/12/2024 09:45

Definitely looks like something is up here.

[peterrr3] 12/12/2024 20:02

Credit where credit is due, they have actually started one of the numerous clinical trials they have registered over the years. Better late than never.Reporting in a year. I don't know where you are getting this imminent news from, certainly not the trial program.https://clinicaltrials.gov/study/NCT06476678?term=Creo%20medical&rank=3

[protrader3] 12/12/2024 18:35

You'll be opening that drawer sooner than you think!

[nimbo10] 12/12/2024 17:09

Joys of investing in AIM, why would anyone bother. Have put in bottom drawer, either kaput or decent recovery. Will be patient for couple of years, just seen capitulation today.